Skip to search formSkip to main contentSkip to account menu

KRP-203

Known as: 2-Amino-2-propanediol Hydrochloride, KRP203, S1P Receptor Agonist KRP203 
The hydrochloride salt form of 2-amino-2 propanediol (KRP-203), a sphingosine 1-phosphate (S1P) receptor agonist, with potential immunosuppressive… 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Immunosuppressive AgentsSulfhydryl Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
PJ-531 A Novel Sphingosine-1-Phosphate Receptor Agonist KRP-203 Attenuates the Development of Experimental Autoimmune Myocarditis(Myocarditis, basic/clinical-2, The 71st Annual Scientific Meeting of…
2006
2006
Change from cyclosporine to combination therapy of mycophenolic acid with the new sphingosine-1-phosphate receptor agonist, KRP-203, prevents host nephrotoxicity and transplant vasculopathy in rats.
2005
2005
A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
Review
2005
Review
2005
[Clinical views from the forefront of immunosuppressive drugs].
Recently, many immunosuppressants have been developed and some of them have already been introduced in clinical organ… 
2004
2004
A NEW SYNTHETIC IMMUNOMODULATOR, KRP-203, ABROGATES CHRONIC REJECTION IN A RAT HEART TRANSPLANTATION MODEL
2004
2004
COMBINATION THERAPY OF KRP-203, A NOVEL SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST, WITH CYCLOSPORINE ABROGATES ACUTE REJECTION WITHOUT ADVERSE EFFECTS – A COMPARATIVE STUDY WITH FTY720 –
2004
2004
IMPACT OF KRP-203, A NOVEL SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST, ON SURVIVAL OF ALLOGENEIC SKIN GRAFTS AND BRADYCARDIA IN RATS AND MICE
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)